Ultima-CJC1295 2mg-int
ACTIVE HALF-LIFE: Long (approximately 5-8 days). CLASSIFICATION: Peptide hormone. DOSAGE: Microgram doses; follow medical advice. ACNE: No WATER RETENTION: Minimal. HBR: No HEPATOTOXICITY: Low risk. AROMATIZATION: No
Semaglutide 5mg+ Etho - Testosterone 300mg
CLASSIFICATION: Incretin Mimetics MANUFACTURER: Beligas Pharmaceuticals SUBSTANCE:Â Glucagon-like Peptide-1
MYO Myostatin 1mg
Brand: Beligas Active Ingredient: Myostatin Active Half-Life: 2-3 Days Classification:Â Oral Steroid Dosage: 1mg Acne: No Water Retention: N Hepatotoxicity: No Aromatization: No
Beligas Semaglutide + Bacteriostatic Water
CLASSIFICATION: Incretin Mimetics MANUFACTURER: Beligas Pharmaceuticals SUBSTANCE:Â Glucagon-like Peptide-1
GHRP-6 - 10mg/vial - Deus Medical
ACTIVE HALF-LIFE:Â 2.5 hours CLASSIFICATION:Â Growth Hormone Secretagogue Receptor Agonist DOSAGE:Â 100-300 mcg/day ACNE:Â No WATER RETENTION:Â No HBR:Â No HEPATOTOXICITY:Â No AROMATIZATION:Â No MANUFACTURER:Â Deus Medical SUBSTANCE:Â Growth Hormone-Releasing Peptide 6
MT-2 10mg
Oxytocin 2mg
Brand Name: Beligas Ingredient: Oxytocin 2mg/5mg Dosage: Dosages Dependent On Indication And Route Of Administration The box includes 1 vial of bacteriostatic water.
GHRP-2 5mg
Product Name: Ghrp 2 Brand Name: Beligas Ingredient: Ghrp-2 Dosage: 5mg
BPC 157 2mg
Brand Name: Beligas Ingredient: Bpc 157 Dosage: 250-500 Mcg/Day
Gonadorelin 2mg
Brand Name: Beligas Ingredient: Gonadorelin Dosage: 100-200 Mcg/dose, May Vary Based on Application
Ultima-CJC1295 no DAC 2mg-int
ACTIVE HALF-LIFE: Long (approximately 5-8 days). CLASSIFICATION: Peptide hormone. DOSAGE: 100 to 1000 micrograms (0.1 to 1 mg) per injection ACNE: No WATER RETENTION: Minimal. HBR:No HEPATOTOXICITY: No AROMATIZATION: No
PT-141 - 10mg/vial - Bremelanotide - Deus Medical
ACTIVE HALF-LIFE: CLASSIFICATION:Â Melanocortin Receptor Agonists <strong>DOSAGE: ACNE:Â No WATER RETENTION:Â No HBR:Â No HEPATOTOXICITY:Â No AROMATIZATION:</strong>Â No<br />MANUFACTURER:Â Deus Medical SUBSTANCE:</strong>Â Bremelanotide














